These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37426013)

  • 21. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.
    Yang H; Li Z; Lin H; Wang W; Yang J; Liu L; Zeng X; Wu Y; Yu Y; Li Y
    Arch Virol; 2016 Jun; 161(6):1517-26. PubMed ID: 26976137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic Amino Acid Substitution at Residue 367 of the Envelope Protein of Tembusu Virus Plays a Critical Role in Pathogenesis.
    Sun M; Zhang L; Cao Y; Wang J; Yu Z; Sun X; Liu F; Li Z; Liu P; Su J
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32024774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantial Attenuation of Virulence of Tembusu Virus Strain PS Is Determined by an Arginine at Residue 304 of the Envelope Protein.
    Yang L; Liang T; Lv J; Qu S; Meng R; Yang B; Feng C; Dai W; Wang X; Zhang B; Zhang D
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33328312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice.
    Nath B; Vandna ; Saini HM; Prasad M; Kumar S
    Vaccine; 2020 Feb; 38(7):1860-1868. PubMed ID: 31955960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes.
    Nam JH; Wyatt LS; Chae SL; Cho HW; Park YK; Moss B
    Vaccine; 1999 Jan; 17(3):261-8. PubMed ID: 9987162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.
    Song BH; Yun GN; Kim JK; Yun SI; Lee YM
    J Microbiol; 2012 Aug; 50(4):698-706. PubMed ID: 22923123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
    Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.
    de Wispelaere M; Ricklin M; Souque P; Frenkiel MP; Paulous S; Garcìa-Nicolàs O; Summerfield A; Charneau P; Desprès P
    PLoS Negl Trop Dis; 2015; 9(10):e0004081. PubMed ID: 26437302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.
    Konishi E; Pincus S; Paoletti E; Laegreid WW; Shope RE; Mason PW
    Virology; 1992 Sep; 190(1):454-8. PubMed ID: 1326813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Delivery of a DNA Vaccine Expressing the PrM and E Genes: A Promising Vaccine Strategy against Flavivirus in Ducks.
    Huang J; Jia R; Shen H; Wang M; Zhu D; Chen S; Liu M; Zhao X; Wu Y; Yang Q; Yin Z; Cheng A
    Sci Rep; 2018 Aug; 8(1):12360. PubMed ID: 30120326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate.
    Hua RH; Li YN; Chen ZS; Liu LK; Huo H; Wang XL; Guo LP; Shen N; Wang JF; Bu ZG
    BMC Biotechnol; 2014 Jul; 14():62. PubMed ID: 25011456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Neutralizing Antibody Response Elicited by Tembusu Virus Is Affected Dramatically by a Single Mutation in the Stem Region of the Envelope Protein.
    Lv J; Liu X; Cui S; Yang L; Qu S; Meng R; Yang B; Feng C; Wang X; Zhang D
    Front Microbiol; 2020; 11():585194. PubMed ID: 33193231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon.
    Suzuki R; Ishikawa T; Konishi E; Matsuda M; Watashi K; Aizaki H; Takasaki T; Wakita T
    J Gen Virol; 2014 Jan; 95(Pt 1):60-65. PubMed ID: 24096319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties.
    Chambers TJ; Nestorowicz A; Mason PW; Rice CM
    J Virol; 1999 Apr; 73(4):3095-101. PubMed ID: 10074160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.